Investing IdeasBrowse All StocksMarkets
Have your own idea? Try our Stock Screener
Header cover image

Norwegian (OSEAX) Healthcare Sector Analysis

UpdatedMay 23, 2025
DataAggregated Company Financials
Companies24
  • 7D0.3%
  • 3M3.9%
  • 1Y-22.0%
  • YTD1.8%

In the last week, the Healthcare industry is up 3.2%, with Lytix Biopharma leading the way with a 33% gain. Meanwhile, SoftOx Solutions actually underperformed within the industry, shrinking 22% in the last week. In the past year, the industry is down 21%. Looking forward, earnings are forecast to grow by 54% annually.

Sector Valuation and Performance

Has the Norwegian Healthcare Sector valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Fri, 23 May 2025NOK 17.0bNOK 3.9b-NOK 1,271,478,490.1127.6x-13.4x4.4x
Sun, 20 Apr 2025NOK 15.6bNOK 3.5b-NOK 1,218,256,741.1917x-12.8x4.5x
Tue, 18 Mar 2025NOK 16.5bNOK 3.4b-NOK 1,238,657,384.9617.4x-13.3x4.8x
Thu, 13 Feb 2025NOK 16.9bNOK 3.8b-NOK 1,154,043,057.3124.8x-14.7x4.5x
Sat, 11 Jan 2025NOK 15.9bNOK 3.8b-NOK 1,111,500,890.5124.7x-14.3x4.2x
Mon, 09 Dec 2024NOK 15.2bNOK 3.7b-NOK 983,369,007.0821.6x-15.5x4.1x
Wed, 06 Nov 2024NOK 16.9bNOK 4.0b-NOK 986,207,812.9319.7x-17.1x4.2x
Fri, 04 Oct 2024NOK 18.4bNOK 4.0b-NOK 963,568,080.4520.4x-19.1x4.6x
Sun, 01 Sep 2024NOK 19.3bNOK 4.0b-NOK 879,596,177.7018.7x-21.9x4.8x
Tue, 30 Jul 2024NOK 22.2bNOK 4.0b-NOK 982,876,285.3916.8x-22.6x5.5x
Thu, 27 Jun 2024NOK 22.2bNOK 4.1b-NOK 949,885,989.5415.5x-23.3x5.4x
Sat, 25 May 2024NOK 22.5bNOK 4.2b-NOK 1,167,111,325.3517.6x-19.3x5.3x
Mon, 22 Apr 2024NOK 21.1bNOK 4.2b-NOK 1,137,079,771.3427.1x-18.6x5x
Wed, 20 Mar 2024NOK 21.6bNOK 4.2b-NOK 1,084,436,183.7927.7x-19.9x5.1x
Fri, 16 Feb 2024NOK 28.7bNOK 4.1b-NOK 1,273,563,127.4324x-22.5x7x
Sun, 14 Jan 2024NOK 30.2bNOK 4.1b-NOK 1,580,016,420.0023.9x-19.1x7.4x
Tue, 12 Dec 2023NOK 28.0bNOK 4.1b-NOK 1,599,272,503.0021.3x-17.5x6.8x
Thu, 09 Nov 2023NOK 27.0bNOK 3.7b-NOK 1,738,236,205.0025x-15.6x7.4x
Sat, 07 Oct 2023NOK 27.2bNOK 3.6b-NOK 1,805,595,555.0033.3x-15.1x7.6x
Mon, 04 Sep 2023NOK 28.6bNOK 3.6b-NOK 1,776,905,210.0031.9x-16.1x8x
Wed, 02 Aug 2023NOK 29.8bNOK 3.4b-NOK 1,821,859,620.0030.3x-16.4x8.8x
Fri, 30 Jun 2023NOK 28.5bNOK 3.4b-NOK 1,801,402,723.0043x-15.8x8.4x
Sun, 28 May 2023NOK 30.5bNOK 3.4b-NOK 1,832,198,782.0043x-16.7x9x
Tue, 25 Apr 2023NOK 30.9bNOK 3.1b-NOK 1,781,079,629.0031.5x-17.4x9.8x
Thu, 23 Mar 2023NOK 28.5bNOK 3.1b-NOK 1,870,171,228.0031.1x-15.2x9.2x
Sat, 18 Feb 2023NOK 33.1bNOK 3.7b-NOK 1,896,302,614.0032x-17.4x9x
Mon, 16 Jan 2023NOK 33.1bNOK 3.6b-NOK 1,834,241,045.0035.4x-18x9.2x
Wed, 14 Dec 2022NOK 35.7bNOK 3.6b-NOK 1,829,082,967.0035.3x-19.5x10x
Fri, 11 Nov 2022NOK 33.6bNOK 3.5b-NOK 1,752,498,305.0039.6x-19.2x9.5x
Sun, 09 Oct 2022NOK 31.4bNOK 3.5b-NOK 1,776,305,740.0058.2x-17.7x9.1x
Tue, 06 Sep 2022NOK 34.6bNOK 3.4b-NOK 1,757,986,202.0056.8x-19.7x10.1x
Thu, 04 Aug 2022NOK 38.7bNOK 3.3b-NOK 1,739,731,684.0090.2x-22.2x11.8x
Sat, 02 Jul 2022NOK 36.6bNOK 3.3b-NOK 1,727,604,806.0056.9x-21.2x11.2x
Mon, 30 May 2022NOK 37.7bNOK 3.6b-NOK 1,320,943,420.0048.1x-28.6x10.5x
Price to Earnings Ratio

-28.6x


Total Market Cap: NOK 37.7bTotal Earnings: -NOK 1,320,943,420.00Total Revenue: NOK 3.6bTotal Market Cap vs Earnings and Revenue0%0%0%
Norwegian Healthcare Sector Price to Earnings3Y Average -18.1x202320242025
Current Industry PE
  • Investors are pessimistic on the Norwegian Healthcare industry, indicating that they anticipate long term growth rates will be lower than they have historically.
  • The 3-year average PS ratio of 7.2x is higher than the industry's current PS ratio of 4.4x.
Past Earnings Growth
  • The earnings for companies in the Healthcare industry have improved over the last three years.
  • Revenues for these companies have grown 2.9% per year.
  • This means that more sales are being generated by these companies overall, and subsequently losses are decreasing too.

Industry Trends

Which industries have driven the changes within the Norwegian Healthcare sector?

NO Market-0.22%
Healthcare0.26%
Healthcare Services12.31%
Medical Equipment2.13%
Pharma0.37%
Healthtech-0.74%
Biotech-2.10%
Industry PE
    Forecasted Growth
    • Analysts are most optimistic on the Healthtech industry, expecting annual earnings growth of 117% over the next 5 years.
    • This is better than its past earnings decline of 60% per year.
    • In contrast, the Medical Equipment industry is expected to see its earnings grow by 4.2% per year over the next few years.

    Top Stock Gainers and Losers

    Which companies have driven the market over the last 7 days?

    CompanyLast Price7D1YValuation
    		MEDI MedistimNOK 212.002.9%
    +NOK 109.5m    		13.7%PE31.5x
    		INIFY INIFY LaboratoriesNOK 7.3012.3%
    +NOK 63.1m    		-18.9%n/a
    		LYTIX Lytix BiopharmaNOK 8.003.9%
    +NOK 20.5m    		50.9%PS898.2x
    		ONCIN OncoinventNOK 1.7811.9%
    +NOK 18.6m    		n/aPS21.5x
    		OMDA OmdaNOK 52.801.5%
    +NOK 16.4m    		53.9%PS2.4x
    Simply Wall St™
    Simply Wall Street Pty Ltd
    Level 7, 320 Pitt Street, Sydney
    Download on the App StoreGet it on Google Play
    Popular Markets
    USAUUKINCAZA
    About UsCareersPlans & PricingLogin
    Help CenterLatest CoveragePodcastsAffiliate ProgramBusiness & EnterpriseWhat's New
    Financial Services GuideTerms and ConditionsPrivacy Policy
    Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.

    Latest News

    OMDA

    NOK 52.80

    Omda

    7D

    1.5%

    1Y

    53.9%

    Omda AS (OB:OMDA) Stock Rockets 32% As Investors Are Less Pessimistic Than Expected

    May 23
    Omda AS (OB:OMDA) Stock Rockets 32% As Investors Are Less Pessimistic Than Expected

    EXTX

    NOK 2.46

    EXACT Therapeutics

    7D

    -20.6%

    1Y

    -65.4%

    HBC

    NOK 2.25

    Hofseth BioCare

    7D

    -3.8%

    1Y

    7.1%

    NORDH

    NOK 38.00

    Nordhealth

    7D

    -1.0%

    1Y

    9.8%

    LIFE

    NOK 8.92

    Lifecare

    7D

    10.4%

    1Y

    -68.8%

    LYTIX

    NOK 8.00

    Lytix Biopharma

    7D

    3.9%

    1Y

    50.9%

    CONTX

    NOK 4.91

    ContextVision

    7D

    2.3%

    1Y

    -15.6%

    MEDI

    NOK 212.00

    Medistim

    7D

    2.9%

    1Y

    13.7%

    Medistim ASA (OB:MEDI) Stock Rockets 31% As Investors Are Less Pessimistic Than Expected

    May 13
    Medistim ASA (OB:MEDI) Stock Rockets 31% As Investors Are Less Pessimistic Than Expected

    GENT

    NOK 56.00

    Gentian Diagnostics

    7D

    -1.8%

    1Y

    41.4%

    Market Participants Recognise Gentian Diagnostics ASA's (OB:GENT) Revenues Pushing Shares 27% Higher

    May 09
    Market Participants Recognise Gentian Diagnostics ASA's (OB:GENT) Revenues Pushing Shares 27% Higher

    NYKD

    NOK 2.62

    Nykode Therapeutics

    7D

    -1.4%

    1Y

    -82.3%

    NAVA

    NOK 22.00

    Navamedic

    7D

    3.8%

    1Y

    -36.6%

    ONCIN

    NOK 1.78

    Oncoinvent

    7D

    11.9%

    1Y

    n/a

    ZLNA

    NOK 13.03

    Zelluna

    7D

    -6.2%

    1Y

    n/a

    TRMED

    NOK 2.45

    Thor Medical

    7D

    -1.4%

    1Y

    131.6%

    INIFY

    NOK 7.30

    INIFY Laboratories

    7D

    12.3%

    1Y

    -18.9%

    SOFTX

    NOK 0.083

    SoftOx Solutions

    7D

    -7.4%

    1Y

    -13.5%